These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 14500946)
1. Intellectual property. U.S. Court opens door to free trade in ideas. Malakoff D Science; 2003 Sep; 301(5640):1643. PubMed ID: 14500946 [No Abstract] [Full Text] [Related]
2. Realizing two-tiered innovation policy through drug regulation. Ridgway WE Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807 [No Abstract] [Full Text] [Related]
3. Pharmaceutical patents and some international trade issues: Canada, the United States, and NAFTA. Tancer RS Clin Ther; 1993; 15(6):1177-84; discussion 1120. PubMed ID: 8111813 [TBL] [Abstract][Full Text] [Related]
4. Intellectual property. Fixing the legal framework for pharmaceutical research. Knowles SM Science; 2010 Feb; 327(5969):1083-4. PubMed ID: 20150445 [No Abstract] [Full Text] [Related]
6. Encouraging further innovation: Ariad v. Eli Lilly and the written description requirement. Jakas J Seton Hall Law Rev; 2012; 42(3):1287-36. PubMed ID: 22803220 [No Abstract] [Full Text] [Related]
7. An overview of pharmaceutical cocrystals as intellectual property. Trask AV Mol Pharm; 2007; 4(3):301-9. PubMed ID: 17477544 [TBL] [Abstract][Full Text] [Related]
8. Intellectual property. U.S. patent reform begins long journey through Congress. Kintisch E Science; 2005 Jun; 308(5729):1725-6. PubMed ID: 15961638 [No Abstract] [Full Text] [Related]
9. [Intellectual property rights and right of access to medicines]. Velásquez G Med Trop (Mars); 2006 Dec; 66(6):526-8. PubMed ID: 17286013 [TBL] [Abstract][Full Text] [Related]
10. Intellectual property. NIH weighs demand to force sharing of AIDS drug patents. Malakoff D Science; 2004 Jun; 304(5676):1427-9. PubMed ID: 15178775 [No Abstract] [Full Text] [Related]
11. Intellectual property and its role in the pharmaceutical industry. Atkinson JD; Jones R Future Med Chem; 2009 Dec; 1(9):1547-50. PubMed ID: 21425976 [No Abstract] [Full Text] [Related]
12. Health-care patents and interests of patients. Luthra R Bull World Health Organ; 2006 Nov; 84(11):919. PubMed ID: 17143470 [No Abstract] [Full Text] [Related]
14. Incentive to be inventive. Nat Rev Drug Discov; 2005 Jul; 4(7):523. PubMed ID: 16060056 [No Abstract] [Full Text] [Related]
15. Big companies helped by safe harbour ruling. Frantz S Nat Rev Drug Discov; 2005 Jul; 4(7):525-6. PubMed ID: 16075481 [No Abstract] [Full Text] [Related]
16. Staving off death: a case study of the pharmaceutical industry's strategies to protect blockbuster franchises. Gorlin DI Food Drug Law J; 2008; 63(4):823-64. PubMed ID: 19601385 [No Abstract] [Full Text] [Related]
17. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States. Miller CP; Ullrich JW Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591 [TBL] [Abstract][Full Text] [Related]
18. Intellectual property. Drug patents at the Supreme Court. Hemphill CS; Sampat B Science; 2013 Mar; 339(6126):1386-7. PubMed ID: 23520096 [No Abstract] [Full Text] [Related]
19. Pills, patents, and power: state creation of gray markets as a limit on patent rights. Ghosh S Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138 [No Abstract] [Full Text] [Related]